Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
38,900
-2,050 (-5.01%)
At close: Jun 10, 2026
Market Cap321.99B +0.7%
Revenue (ttm)16.82B +53.7%
Net Income-36.35M
EPS-4.47
Shares Out 8.28M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume49,796
Open39,600
Previous Close40,950
Day's Range38,500 - 41,700
52-Week Range37,500 - 101,000
Betan/a
AnalystsStrong Buy
Price Target97,666.67 (+151.07%)
Earnings DateAug 14, 2026

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 389650 stock is "Strong Buy." The 12-month stock price target is ₩97,667, which is an increase of 151.07% from the latest price.

Price Target
₩97,667
(151.07% upside)
Analyst Consensus: Strong Buy
Stock Forecasts